Research enables innovation and provides options to patients who may benefit from novel approaches to treatment and care. The members of the UBC Division of Hematology are active across a broad spectrum of hematological disorders, including both benign and malignant conditions.
The UBC Division of Hematology pioneers investigation in clinical, translational and basic sciences attracting talent and collaboration locally and from around the world. The Division is internationally-renowned for its strong clinical expertise and translational approaches in hematology. For more information on our members, please see Faculty.
The research is supported through the Hematology Research Program (HRP) and the Hematology Cell Bank of British Columbia (HCB) along with collaboration with our various colleagues at the BC Genome Sciences Centre, the Terry Fox Laboratory, the BC Cancer Research Centre, the UBC Centre for Blood Research and other associate centres.
Support world-class hematology research right here in Vancouver through the VGH + UBC Hospital Foundation.
Areas of Active Research
- acute biphenotypic leukemiaacute lymphoblastic leukemia (ALL)
- acute myeloid leukemia (AML)
- bone marrow transplant (BMT)
- cancer-associated thrombosis
- chronic lymphocytic leukemia (CLL)
- chronic myeloid leukemia (CML)
- complement activation
- Graft-Versus-Host Disease (GVHD)
- hemophilias A & B
- idiopathic thrombocytopenic purpura (ITP)
- multiple myeloma
- myelodysplastic syndromes (MDS)
- myeloproliferative neoplasms (MPNs)
- non-Hodgkin lymphomas (NHLs)
- paroxysmal nocturnal hemoglobinuria (PNH)
- perioperative management
- supportive care strategies
- thrombotic thrombocytopenic purpura (TTP)
- transfusion medicine
- venous thromboembolism &
- von Willebrand Disease
- other blood-related conditions